Elanco: Innovation Is Turning A Leveraged Portfolio Into A Share-Taking PlatformSeeking Alpha • 08/12/26
Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife SpeciesPRNewsWire • 08/07/26
Elanco Animal Health (ELAN) Reports Q2 Earnings: What Key Metrics Have to SayZacks Investment Research • 08/05/26
Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat EstimatesZacks Investment Research • 08/05/26
Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society's Growing NeedsPRNewsWire • 07/31/26
Elanco Animal Health Incorporated (ELAN) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 07/29/26
Are You Looking for a Top Momentum Pick? Why Elanco Animal Health Incorporated (ELAN) is a Great ChoiceZacks Investment Research • 07/22/26
Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Kills Ticks¹ Faster² than Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) and NexGard® Plus (afoxolaner, moxidectin, and pyrantel chewable tablets)PRNewsWire • 07/22/26
Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results AnnouncementPRNewsWire • 07/08/26
Is the Options Market Predicting a Spike in Elanco Animal Health Stock?Zacks Investment Research • 06/30/26
Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal HealthPRNewsWire • 06/18/26
Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for DogsPRNewsWire • 06/15/26
Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World ScrewwormPRNewsWire • 06/04/26
New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry ResiliencePRNewsWire • 06/03/26
Elanco Animal Health Incorporated (ELAN) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks TranscriptSeeking Alpha • 06/02/26
Elanco Animal Health Incorporated (ELAN) Presents at Stifel Jaws & Paws Conference 2026 TranscriptSeeking Alpha • 05/27/26
Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology MarketPRNewsWire • 05/18/26